Back to Journals » Drug Design, Development and Therapy » Volume 16

Curcumin Protects Against Myocardial Infarction-Induced Cardiac Fibrosis via SIRT1 Activation in vivo and in vitro [Corrigendum]

Authors Xiao J, Sheng X, Zhang X, Guo M, Ji X

Received 23 December 2021

Accepted for publication 23 December 2021

Published 14 February 2022 Volume 2022:16 Pages 343—344

DOI https://doi.org/10.2147/DDDT.S355505



Xiao J, Sheng X, Zhang X, Guo M, Ji X. Drug Des Devel Ther. 2016;10:1267–1277.

The authors have advised due to an error at the time of figure assembly, Figure 5A on page 1274 is incorrect. The correct Figure 5 is shown in Download Article.

The authors apologize for this error and advise it does not affect the results of the paper.

Read the original article

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.